Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Pioglitazone hydrochloride
As low as
CHF 58.00
In stock
Only %1 left
CDX-P0733-M01010 mgCHF 58.00
CDX-P0733-M05050 mgCHF 232.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride; U 72107A |
| Product Type | Chemical |
| Properties | |
| Formula | C19H20N2O3S . HCl |
| MW | 392.9 |
| CAS | 112529-15-4 |
| RTECS | XJ5813440 |
| Source/Host Chemicals | Synthetic |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | White to off-white powder. |
| Solubility | Soluble in DMSO or DMF (both 10mg/ml). |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by Chemodex. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| InChi Key | GHUUBYQTCDQWRA-UHFFFAOYSA-N |
| Smiles | CCC(C=C1)=CN=C1CCOC2=CC=C(CC3SC(NC3=O)=O)C=C2.Cl |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +20°C |
| Long Term Storage | +20°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at RT. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
Pioglitazone hydrochloride is a proliferator-activated receptor γ (PPARγ) agonist (EC50 = ~500-600nM for both human and murine PPARγ) and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) and to a lesser extent PPAR-α. Pioglitazone hydrochloride is usually used to treat type-II diabetes in vivo and has the ability to block hepatic gluconeogenesis. Pioglitazone inhibits pyruvate oxidation and glucose production in hepatocytes when used at a concentration of 10 μM. In vivo, pioglitazone (0.3-3mg/kg per day) reduces hyperglycemia, hyperlipidemia, and hyperinsulinemia in a dose-dependent manner in male Wistar fatty rats. It shos also anti-inflammatory and anti-arteriosclerosis effects.
Product-specific References
(1) Y. Sugiyama, et al.; Arzneimittelforschung 40, 263 (1990) | (2) J.M. Lehmann, et al.; J. Biol. Chem. 270, 12953 (1995) | (3) T.M. Willson, et al.; J. Med. Chem. 39, 665 (1996) | (4) J. Sakamoto, et al.; BBRC 278, 704 (2000) | (5) T.M. Willson, et al.; J. Med. Chem. 43, 527 (2000) | (6) M. Ishibashi, et al.; Hypertension 40, 687 (2002) | (7) P. de Pablos-Velasco; Expert Rev. Cardiovasc. Ther. 8, 1057 (2010) | (8) C. Ao, et al.; Cell Biol. Int. 34, 723 (2010) | (9) H.L. Zhang, et al.; Neuroscience 176, 381 (2011) | (10) Q. Zhao, et al.; J. Neuroinflamm. 13, 259 (2016) | (11) S. Suzuki, et al.; Int. J. Mol. Sci. 17, E2071 (2016) | (12) C.E. Shannon, et al.; FEBS J. 284, 451 (2017)
You're in the Switzerland store. Not in Switzerland? Choose your country
You're in the Switzerland store (prices in CHF, shipping to Switzerland only). Ordering from another country? Please select it below.
Please note that not all products are available in every country store. Choose your country before starting the ordering process.
Country
Switzerland
United Kingdom
France
Germany
Austria
Italy
South Korea
United States
Argentina
Australia
Belgium
Bosnia and Herzegovina
Brazil
Canada
Chile
China
Colombia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
Greece
Hong Kong
Hungary
India
Iran
Iraq
Ireland
Israel
Japan
Latvia
Lithuania
Luxembourg
Malaysia
Mexico
Netherlands
New Zealand
Norway
Pakistan
Peru
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Syria
Taiwan
Thailand
Turkey
Uruguay
Venezuela
Other Country
No country found




Download PDF